Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

243.50 -1.05 (-0.43%)
Streaming Delayed Price Updated: 1:22 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Janssen celebrates World Mental Health Day to raise awareness on the importance of timely diagnosis and treatment
Janssen, Pharmaceutical Companies of Johnson & Johnson, is immensely proud of the many ground-breaking mental health innovations has pioneered over the course of its 60+ year legacy in the field. 
Via Newswire.com
News headline image
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
News headline image
3 Defensive Stocks With 60-Year Dividend Hike Streaks
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs. 
Via MarketBeat
Topics Economy
News headline image
OrPro Therapeutics Receives $2.147M Therapeutic Development Funding from US Department of Defense for COVID-19 and Influenza
Prestigious CDMRP award will advance development of ORP100S as an inhaled treatment for acute and chronic respiratory diseasesSAN DIEGO - July 19, 2022 - PRLog -- OrPro Therapeutics, Inc., a San Diego... 
Via PRLog
Topics Derivatives
News headline image
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
From Johnson & Johnson
Via Business Wire
News headline image
Oracle’s Short-Term Pain Could Be Your Long-Term Gain
Database and cloud solutions provider Oracle (NASDAQ: ORCL) stock got smoked on its fiscal Q1 2023 earnings report. Shares were holding up relatively 
Via MarketBeat
News headline image
Johnson & Johnson Announces $5 Billion Share Repurchase Program
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
Via AB Newswire
News headline image
aCommerce and Johnson & Johnson Launch Sustainable Packaging Solution for a Better E-commerce Future in the Philippines
Via ACN Newswire
News headline image
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),... 
Via SBWire
News headline image
Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
Low volatility dividend plays are built to show their worth over time. These three stocks have historically helped navigate investors through turbulent waters. 
Via MarketBeat
Topics Economy Stocks
News headline image
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
News headline image
Agilis Consulting Group Appoints Former Johnson & Johnson Employee, Denise Wagner, as Principal Human Factors Consultant
Agilis is looking forward to continued growth with Denise as the Principal Consultant to help clients achieve their regulatory goals and create safer medical products for the end users. 
Via Newswire.com
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via Investor Brand Network
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill... 
Via FinancialNewsMedia
News headline image
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
News headline image
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
News headline image
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Church & Dwight (NYSE: CHD) might not exactly be a household name, but you've likely heard of many of the company's brands: ARM & HAMMER, Trojan, First Response, Nair, Spinbrush, OxiClean, Orajel,... 
Via MarketBeat
News headline image
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could... 
Via FinancialNewsMedia
News headline image
MarketBeat: Week in Review 7/18 – 7/22
Investors should be careful not to read too much into this week's rally. Next week will bring the Fed's decision on interest rates and key earnings reports from the tech sector. Both could cause... 
Via MarketBeat
Topics Economy
News headline image
Vaccines Market Expected to Witness a Sustainable Growth by 2032 - Future Market Insights, Inc.
FMI predicts vaccines market to reach a valuation of US $120B by 2032. Key Players - Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson &... 
Via Newswire.com
News headline image
Healthcare Education Solutions Market Analysis, Size, Share, Trends, Global Industry Overview, Demand, Growth and Forecast 2028 Zimmer Biomet, Stryker, Medtronic, Canon Medical, Johnson & Johnson, FUJIFILM Holding, Olympus
Healthcare Education Solutions Market 2022 Industry Size, Share, Global Analysis, Growth, Development Status, Regional Trends, Opportunity Assessment and Comprehensive Research Study Forecast with... 
Via SBWire
News headline image
Johnson & Johnson Reports Q2 2022 Results
From Johnson & Johnson
Via Business Wire
News headline image
Is it Time to Cash Out Novavax Stock?
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S. 
Via MarketBeat
News headline image
Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Continues to Prove its Value in a Volatile Year
Johnson & Johnson is scheduled to release its second quarter earnings report on July 19, 2022. Low single-digit growth may not do much to excite investors. But in this article, we’ll take a closer look... 
Via MarketBeat
Topics Economy
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.